Intraoperative breast cancer margin evaluation using fluorescence imaging with intravenous injection of indocyanine green (BREASTIFLU-1): study protocol for a randomized diagnostic accuracy trial of quantitative dose-timing assessment.
AuteursPop CF, Veys I, Moreau M, Paesmans M, De Azambuja E, Larsimont D, Liberale G
RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer.
AuteursLlop-Guevara A, Pellegrino B, Pimentel I, Villacampa G, Solinas C, Torres-Esquius S, Campanini N, Simonetti S, Tommasi C, Serra O, Corianò M, Boggiani D, Michiara M, Minari R, Bortesi B, Rapacchi E, Dieci MV, Lambertini M, Zoppoli G, Schirone A, Casarini C, Cretella E, Cortesi L, Silini EM, Saura C, Willard-Gallo K, Boisson A, Musolino A, Serra V, Balmaña J, Cruz C
Understanding the patient journey: Barriers, facilitators, and expectations in joining a chemotherapy de-escalation trial among premenopausal patients with breast cancer.
AuteursZyumbileva P, Spanic T, Gillanders E, Martin E, Zambon M, Connolly M, Dutarte M, Tricanico E, Caballero C, El-Abed S, Dunn J, Merckaert I, Macpherson IR, Vanhecke A, Vaz-Luis I, Franzoi MA
\"When Immunity Backfires: meta-analysis on Sarcoidosis Reactivation in Cancer Patients Treated with Immune Checkpoint Inhibitors\".
AuteursMartella S, Cusumano G, Stylianakis D, Wolff L, Porcu M, Lambertini M, Saba L, Denaro N, Scartozzi M, Buisseret L, Bondì G, Vancheri C, Solinas C
